Tradestie Institutional Equity Comparison Engine

IMTX vs MLTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MLTX Overall Edge

MLTX Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) driven by superior Momentum & Technical, Options & Structure while IMTX counters with relative strength in Growth & Margin. Fundamentally, IMTX trades at N/M Forward P/E with -577.1% operating margin (+33.5% YoY revenue) versus MLTX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, IMTX sits in BREAKDOWN (84th %ile IV; Dealer Gamma Walls on Pro) against MLTX sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
IMTX N/M vs MLTX N/M Fwd P/E
Growth & Margin Winner IMTX
Op Margin -577.1% vs 0.0% ยท YoY +33.5% vs +0.0%
Momentum & Technical Winner MLTX
1Y -37.7% vs -5.7% ยท 52W Pos 2% vs 17%
Options & Structure Winner MLTX
BREAKDOWN (84th %ile IV) vs BREAKDOWN (7th %ile IV)
IMTX NASDAQ
Immatics N.V. Ordinary Shares
Biological Products, (No Diagnostic Substances)
$6.21
-2.74% 1D
Market Cap $992.8M
1M Return -7.65%
1Y Return -37.73%
Forward P/E N/M
Unified AI Score
49.7 / 100 HOLD
Tech 56.0 Fund 54.0 Flow 68.0 Mom 64.0
MLTX NASDAQ
MoonLake Immunotherapeutics Class A Ordinary Shares
Pharmaceutical Preparations
$11.85
-5.2% 1D
Market Cap $1.1B
1M Return +24.08%
1Y Return -5.65%
Forward P/E N/M
Unified AI Score
38.3 / 100 SELL
Tech 32.0 Fund 44.0 Flow 75.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMTX -37.73% MLTX -5.65% Spread: +32.08 pp (MLTX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IMTX TTM Op. Margin: -577.1% MLTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMTX vs MLTX. Trailing 12-month operating profitability (IMTX -577.1% vs MLTX 0.0%) and valuation multiples (IMTX N/M vs MLTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMTX (4) vs MLTX (3)
Institutional Metric IMTX MLTX Criterion Row Winner
Market Capitalization Scale $992.8M $1.1B Larger Scale MLTX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +33.5% +0.0% Higher Growth IMTX
Operating Margin (TTM) Profitability -577.1% 0.0% Higher Margin MLTX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -54.3% -81.5% Higher ROE IMTX
52-Week Range Position Momentum 2% ($6โ€“$12) 17% ($9โ€“$23) Stronger Trend MLTX
Beta / 30D Volatility Risk Regime 1.42ฮฒ ยท 54% Vol 1.61ฮฒ ยท 90% Vol Lower Realized Risk IMTX
Unified Institutional Score Composite Signal 49.7 / 100 (HOLD) 38.3 / 100 (SELL) Higher Composite IMTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMTX vs MLTX Buy Guide
IMTX BREAKDOWN
122d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 84th %ile
IV Regime Extreme (>80th %ile)
Live IMTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MLTX BREAKDOWN
103d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live MLTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMTX nor MLTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.